Hidden Toll of CRE Colonization: Tripled Three-Year Mortality Risk and Increased Bloodstream Infection Burden After
Yuan Zhang1, Rong Wang1, Guoqing Lyu1,2,3
1Department of Hematology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan Province, 453100, People's Republic of China.
Infection and Drug Resistance
|February 19, 2026
Summary
Pre-transplant Carbapenem-resistant Enterobacteriaceae (CRE) colonization significantly worsens allogeneic stem cell transplant outcomes, increasing bloodstream infections and mortality. Early screening and decolonization are crucial for improving patient survival.
Area of Science:
- Infectious Diseases
- Hematology
- Transplantation Medicine
Background:
- Carbapenem-resistant Enterobacteriaceae (CRE) colonization is a significant risk factor for allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients.
- Limited data exists on the long-term consequences of CRE colonization and the efficacy of decolonization strategies in this vulnerable population.
Purpose of the Study:
- To evaluate the long-term impact of pre-transplant CRE colonization on allo-HSCT outcomes.
- To assess the incidence of CRE bloodstream infections (BSI) and associated mortality in colonized versus non-colonized patients.
- To investigate the effect of CRE colonization on engraftment, graft-versus-host disease (GVHD), and overall survival (OS).
Main Methods:
- A prospective study of 240 allo-HSCT recipients screened for pre-transplant rectal CRE colonization.
- Inverse probability of treatment weighting (IPTW) was used for covariate balancing.
- Kaplan-Meier curves and Cox proportional hazards models analyzed outcomes including CRE BSI, engraftment, GVHD, and 3-year OS.
Main Results:
- CRE BSI occurred primarily in colonized patients (26.6%) with high strain and enzyme concordance (81.0% and 77.8%) between colonizing and infecting isolates.
- Colonized patients experienced delayed engraftment and earlier chronic GVHD onset.
- 3-year OS was significantly lower in colonized patients (58% vs 83%) with a 3.49-fold increased mortality risk.
Conclusions:
- Pre-transplant CRE colonization is a strong predictor of adverse allo-HSCT outcomes, including increased CRE BSI, mortality, delayed engraftment, and accelerated GVHD.
- CRE colonization represents a modifiable risk factor, underscoring the need for routine screening and targeted decolonization protocols.
- Implementing effective decolonization strategies is essential to improve survival rates in allo-HSCT recipients.
Keywords:
allogeneic hematopoietic stem cell transplantationcarbapenem-resistant Enterobacteriaceaegraft-versus-host-diseaseoverall survival: non-relapse mortalityMore Related Videos
Related Concept Videos
Factors Affecting the Risk of Infection
14.0K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.0K
Regulation of Hematopoietic Stem Cells
4.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
Bone Marrow Sampling and Transplants
1.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.7K
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K


